Cargando…
A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
The interleukin-3 (IL-3) receptor is a cell-surface heterodimer that links the haemopoietic, vascular and immune systems and is overexpressed in acute and chronic myeloid leukaemia progenitor cells. It belongs to the type I cytokine receptor family in which the α-subunits consist of two fibronectin...
Autores principales: | Broughton, Sophie E., Hercus, Timothy R., Nero, Tracy L., Kan, Winnie L., Barry, Emma F., Dottore, Mara, Cheung Tung Shing, Karen S., Morton, Craig J., Dhagat, Urmi, Hardy, Matthew P., Wilson, Nicholas J., Downton, Matthew T., Schieber, Christine, Hughes, Timothy P., Lopez, Angel F., Parker, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785977/ https://www.ncbi.nlm.nih.gov/pubmed/29374162 http://dx.doi.org/10.1038/s41467-017-02633-7 |
Ejemplares similares
-
Unexpected mechanisms of action for a cytokine receptor-blocking antibody
por: Hercus, Timothy R, et al.
Publicado: (2014) -
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
por: Kan, Winnie L., et al.
Publicado: (2023) -
EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018) -
Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019) -
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
por: Panousis, Con, et al.
Publicado: (2015)